Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Learn how a yield-focused dividend ETF can fit into a retirement plan, delivering income while maintaining simplicity and liquidity.
19,425 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
A North American software company behind a scroll-and-earn model says it has topped Deloitte’s fastest-growing list, ...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...
A disciplined fund made million MercadoLibre bets after a 35% slide, betting on a resilient platform in LATAM. This d...
Uber is dialing back its push on wide AI bets, choosing measured investments aimed at ROI and platform reliability. T...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
The Department of Veterans Affairs has finalized a loss mitigation option for veterans with VA-backed mortgages, elim...
The UK regulator has issued a formal warning to soccer clubs about sponsorship deals with cryptocurrency firms. The m...
A Virginia woman sues Outback Steakhouse for $1.5 million after a claimed mashed potato slip-and-fall. The filing und...
Petco's WOOF ticker hints at a pet retailer balancing stores, services, and digital growth. This investor guide break...